Radioimmunotherapy of refractory non-Hodgkin's lymphoma with 131I-labeled chimeric 81C6 anti-tenascin monoclonal antibody:: Dosimetry study.

被引：0
|
作者：
Akabani, G [1 ]
Rizzieri, D [1 ]
Coleman, RE [1 ]
Metzler, SD [1 ]
Zalutsky, MR [1 ]
Bigner, DD [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1259
引用
收藏
页码：313P / 313P
页数：1
相关论文
共 50 条
  • [1] Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
    Rizzieri, DA
    Akabani, G
    Zalutsky, MR
    Coleman, RE
    Metzler, SD
    Bowsher, JE
    Toaso, B
    Anderson, E
    Lagoo, A
    Clayton, S
    Pegram, CN
    Moore, JO
    Gockerman, JP
    DeCastro, C
    Gasparetto, C
    Chao, NJ
    Bigner, DD
    BLOOD, 2004, 104 (03) : 642 - 648
  • [2] Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas:: A phase II study
    Akabani, G
    Reardon, DA
    Coleman, RE
    Wong, TZ
    Metzler, SD
    Bowsher, JE
    Barboriak, DP
    Provenzale, JM
    Greer, KL
    DeLong, D
    Friedman, HS
    Friedman, AH
    Zhao, XG
    Pegram, CN
    McLendon, RE
    Bigner, DD
    Zalutsky, MR
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (06) : 1042 - 1051
  • [3] Human-mouse chimeric 131I-labeled anti-CD20 monoclonal antibody (MAB) in relapsed non-Hodgkin's lymphoma (NHL):: Dosimetry and radioimmunotherapy (RIT).
    Scheidhauer, K
    Baumgartl, HJ
    von Schilling, C
    Schmidt, B
    Wolf, I
    Reidel, G
    Peschel, C
    Schwaiger, M
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 268P - 268P
  • [4] Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma
    Akabani, G
    Rizzieri, DA
    Zalutsky, MR
    Coleman, RE
    Metzler, SD
    Bowsher, JE
    Toaso, B
    Lagoo, A
    Moore, JO
    Gockerman, JP
    DeCastro, C
    Gasparetto, C
    Chao, NJ
    Bigner, DD
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S222 - S222
  • [5] TREATMENT OF INTRACRANIAL HUMAN GLIOMA XENOGRAFTS WITH I-131-LABELED ANTI-TENASCIN MONOCLONAL ANTIBODY-81C6
    LEE, YH
    BULLARD, DE
    HUMPHREY, PA
    COLAPINTO, EV
    FRIEDMAN, HS
    ZALUTSKY, MR
    COLEMAN, RE
    BIGNER, DD
    CANCER RESEARCH, 1988, 48 (10) : 2904 - 2910
  • [6] Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
    Akabani, G
    Reist, CJ
    Cokgor, I
    Friedman, AH
    Friedman, HS
    Coleman, RE
    Zhao, XG
    Bigner, DD
    Zalutsky, MR
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (04) : 631 - 638
  • [7] Dosimetry and dose-response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy
    Akabani, G
    Cokgor, I
    Coleman, RE
    Trotter, DG
    Wong, TZ
    Friedman, HS
    Friedman, AH
    Garcia-Turner, A
    Herndon, JE
    DeLong, D
    McLendon, RE
    Zhao, XG
    Pegram, CN
    Provenzale, JM
    Bigner, DD
    Zalutsky, MR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04): : 947 - 958
  • [8] Patient-specific murine 131I-labeled anti-tenascin monoclonal antibody 81C6 radioimmunotherapy for delivering a 44-GY boost to the resection cavity periphery of patients with newly diagnosed primary malignant brain tumors:: A feasibility pilot study
    Reardon, D.
    Akabani, G.
    Friedman, A.
    Friedman, H.
    Herndon, J.
    McLendon, R.
    Quinn, J.
    Rich, J.
    Vredenburga, J.
    Dejardins, A.
    Sampson, J.
    Gururangan, S.
    Kirkpatrick, J.
    Wong, T.
    Dowell, J.
    Dunn, R.
    Sathornsumettee, S.
    Boutlton, S.
    Coleman, R.
    Zalutsky, M.
    Bigner, D.
    NEURO-ONCOLOGY, 2006, 8 (04) : 489 - 489
  • [9] Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent
    Zalutsky, MR
    Archer, GE
    Garg, PK
    Batra, SK
    Bigner, DD
    NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (04): : 449 - 458
  • [10] Chimeric murine/human IgG2 anti-tenascin 81C6 monoclonal antibody:: phase I trial in patients with malignant glioma of a construct with improved stability
    Zalutsky, M. R.
    Reardon, D. A.
    Quinn, J. A.
    Coleman, R. E.
    Akabani, G.
    Friedman, A. H.
    Friedman, H. S.
    Herndon, J. E., II
    McLendon, R. E.
    Wong, T. Z.
    Bigner, D. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S194 - S194
12345